Cavalier Investments »

Protagonist Therapeutics shares owned by Cavalier Investments

Quarter-by-quarter ownership of Protagonist Therapeutics (PTGX) shares owned by Cavalier Investments from 13F filings

Historical chart of Cavalier Investments investment in Protagonist Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protagonist Therapeutics held by Cavalier Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagonist Therapeutics by Cavalier Investments

Quarter filed Position value Share count Share price at filing
2024-12-31 $1.2M 31k 38.60
2024-09-30 $1.3M 30k 45.00

More positions owned by Cavalier Investments

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Select Sector Spdr Tr Communication (XLC)
Broadcom Call Option (AVGO)
Vaneck Etf Trust Semiconductr Etf (SMH)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Newmont Mining Corporation Call Option (NEM)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Invesco Qqq Tr Unit Ser 1 (QQQ)
JPMorgan Chase & Co. (JPM)
Boston Scientific Corporation (BSX)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Ge Aerospace Com New (GE)

View all positions for Cavalier Investments

Top funds holding Protagonist Therapeutics

BlackRock
Farallon Capital Management
Rtw Investments
Vanguard Group
State Street Corporation
BVF
Johnson & Johnson
Wellington Management Company
UBS Group
Deep Track Capital
Woodline Partners
Geode Capital Management
Driehaus Capital Management
Henderson Group
Marshall Wace

View all funds holding Protagonist Therapeutics